Cell-substratum adhesion in embryonic chick central nervous system is mediated by a 170,000-mol-wt neural-specific polypeptide by unknown
Cell-Substratum  Adhesion 
in Embryonic Chick Central Nervous System Is 
a 170,000-mol-wt  Neural-specific Polypeptide 
Mediated by 
GREGORY  J.  COLE  and  LUIS GLASER 
Department of Biological Chemistry, Division of Biology and Biomedical Sciences, Washington  University 
School of Medicine, St. Louis, Missouri 63110 
ABSTRACT  Embryonal chick neural retina cells release into the culture medium a complex of 
proteins and glycosaminoglycans, termed adherons, that promote cell to substratum  adhesion. 
A  monoclonal  antibody  (C1H3) blocks  adheron-mediated  cell  to  substratum  adhesion and 
specifically binds to a 170,000-mol-wt protein present in retinal adherons (Cole, G. J., and L. 
Glaser,  1984,  J.  Biol.  Chem.,  259:4031-4034).  The  170,000-mol-wt  protein  also  can  be 
identified in embryonic chick brain  and peripheral nervous tissue.  In the neural retina, C1H3 
also binds to a second antigen with a molecular weight of 140,000 that is absent in the brain. 
Embryonic brain, therefore, provides a source for the immunopurification of the 170,000-mol- 
wt protein.  Brain adherons also contain the 170,000-mol-wt protein, and cell to substratum 
adhesion  mediated  by these  adherons  is  blocked  by the  C1H3 monoclonal  antibody.  The 
170,000-mol-wt protein in the brain  is therefore functionally identical to that in the retina. To 
demonstrate that adheron-mediated cell to substratum  adhesion is caused  by cell binding to 
the 170,000-mol-wt protein, we showed that (a) protease digestion, but not glycosaminoglycan 
hydrolase digestion  of adherons,  blocked  their ability to  bind  cells  to  substratum;  (b)  the 
immunopurified  170,000-mol-wt protein  blocks  adheron-mediated cell to substratum  adhe- 
sion; and (c) cells can bind to immunopurified  170,000-mol-wt protein bound to glass surfaces. 
Adhesive  interactions  between  cell  types in  the  developing 
nervous system are likely to be dependent on several distinct 
processes.  A  primary  mode  of interaction  occurs  between 
neurons and is in part mediated by the neural cell adhesion 
molecule,  N-CAM (1).'  Molecules participating  in  neuron- 
neuron interactions that are immunochemically or function- 
ally related to N-CAM have also been described in the nervous 
system  (2-4).  Grumet  et  al.  (5)  have  recently  identified  a 
molecule distinct from N-CAM that participates in adhesion 
between neurons and gila. In addition to these types of cell- 
cell adhesion, extracellular molecules have been implicated in 
cell  adhesion  processes.  Macromolecules that  comprise  the 
extracellular  matrix  provide a  substratum  that  permits  the 
adhesion and migration of developing cells, and thus probably 
play a key role in development. Extracellular molecules that 
are possible candidates in cell-substratum adhesion have been 
identified  in cultured  muscle cells (6,  7) and  fibroblast-like 
cells (8,  9).  Characteristic  of these molecules is their release 
from the cells into the culture medium, and their promotion 
of cell-substratum adhesion when used to coat plastic culture 
dishes. Extracellular macromolecules that are released by non- 
neural  cells  and  permit  cell-substratum  adhesion  of neural 
cells have also been described (I0). In addition, a complex of 
proteins and glycosaminoglycans, termed adherons, 2 has been 
isolated from the culture medium of embryonic chick neural 
retina cells and has specifically been shown to mediate cell- 
substratum adhesion of these neural cells (11). Neural retinal 
cells adhere  specifically to plastic dishes coated with retinal 
' Abbreviations  used in this paper:  buffer A, 8 g NaC1, 0.2 g KCI, 
0.2 g KH:PO4, 0.15  g Na2HPO4/liter (pH 7.4); DME,  Dulbecco's 
minimal essential medium; EBSS, Earle's balanced salt solution; N- 
CAM, neural cell adhesion molecule; NP-40, Nonidet P-40. 
2 The  term  adheron  is  used  operationally  to  describe  particulate 
material  prepared  by the method of Schubert  et al.  (11). It is not 
meant to imply that this material represents a defined macromolec- 
ular aggregate of constant composition. 
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origin have been isolated from muscle cells (6, 7). 
A monoclonal antibody, termed C~H3, was prepared in our 
laboratory using intact embryonic chick neural retina cells as 
an immunogen. In extracts of the neural retina, this mono- 
clonal antibody reacts with two distinct developmentally reg- 
ulated polypeptides with molecular weights of 170,000  and 
140,000  (12).  The  170,000-mol-wt  CIH3  polypeptide  is  re- 
leased from cultured retina cells into the culture medium and 
is a component of adherons (13). The CIH3  antibody abolishes 
adheron-mediated cell to substratum adhesion of retinal cells, 
either when  incubated  with the adherons or with the cells 
before assay. This observation suggests that retinal cell binding 
to adherons is homophilic, i.e., mediated by like molecules-- 
one on the cell, the other in the adheron. Antibody blocking 
experiments are potentially misleading in that the blocking 
effect of the antibody could be due to steric effects.  If the 
adheron-mediated cell to substratum adhesion is due to cell 
binding to the  170,000-mol-wt  protein,  one can expect the 
following: (a) soluble 170,000-mol-wt protein will block adhe- 
sion; (b) cells will bind to 170,000-mol-wt proteins immobi- 
lized on an inert support; and (c) cell to adheron binding will 
be sensitive to digestion with proteolytic enzymes and insen- 
sitive to treatment with glycosaminoglycan hydrolases. Our 
experiments provided evidence that these predictions in fact 
pertain to retinal cell to substratum adhesion. 
We  purified  the  170,000-mol-wt  protein  from  detergent 
extracts ofembryonal chick brain by immunoabsorption. The 
brain is the preferred source for this particular protein since 
the  170,000-mol-wt  immunoreactive  protein,  but  not  the 
140,000-mol-wt immunoreactive protein, is present in brain 
(12). To validate the use of brain as a source of this protein, 
we showed that brain adherons also contain the 170,000-mol- 
wt protein and are functionally indistinguishable from retinal 
adherons. 
MATERIALS  AND  METHODS 
Preparation and  Screening of  Monoclonal  Antibodies: 
Preparation  of the C,H3 monoclonal  antibody  has been described previously 
(12). It was obtained by the immunization of Sprague-Dawley rats with disso- 
ciated day  7 retinal  cells and the fusion  of rat spleen cells with the mouse 
myeloma Sp  2/0  cell line.  The  antibody  was isolated  by  precipitation  of 
immunoglobulins  from culture  medium with  saturated  ammonium sulfate, 
followed by chromatography  on a CM Affi-Gel blue column to remove albu- 
min. 
The  monoclonal  antibody  to  N-CAM  was obtained  from Dr.  David  I. 
Gottlieb  (Washington  University).  It was prepared  by immunizing BALB/c 
mice with mechanically dissociated day 9 retinal cells, and fusing the spleen 
cells with Sp 2/0 myeloma cells (14). The anti-N-CAM antibody used in these 
studies  was obtained  by  injecting  BALB/c  mice  with  hybridoma  cells and 
isolating ascites fluid containing the immunoglobulin. 
Isolation of Adheron Complexes:  Adherons were isolated from 
dissociated retina or brain cells as described by Schubert et al. (11), with some 
modifications.  Our primary modification  was the mechanical  dissociation of 
the embryonic  tissues, as  opposed  to trypsin  dissociation,  before  culturing. 
Embryonic day  11 retinas or day 12 brains were mechanically dissociated with 
a fire-polished Pasteur  pipette and incubated  for 18 h at 37"C in serum-free 
Dulbecco's  minimal essential medium (DME) that contained  transferrin,  in- 
sulin, progesterone, and putrescine (15). Adherons were isolated from condi- 
tioned  medium  as  described  by  Schubert  et  al.  (ll).  Briefly, conditioned 
medium was centrifuged 5 rain at 1,000 g to remove cells, and then centrifuged 
at  12,000 g for 30 rain to remove cell debris. The supernatant fluid was then 
centrifuged 3 h at 100,000 g, the supernatant  was discarded, and the adheron 
pellet was washed twice by centrifugation  with Earle's balanced  salt solution 
(EBSS) (Gibco Laboratories, Grand Island, NY). 
The presence of the C~H3 antigen in isolated adherons  was determined  by 
two separate methods. The first involved dot-blotting of adheron protein onto 
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nitrocellulose (16), followed by incubation  with C~H3 monoclonal  antibody 
and horseradish peroxidase-conjugated goat anti-rat IgG (Cappel Laboratories, 
Cochranville,  PA). Antigen was then visualized by reaction  of the filter with 
3,3'-diaminobenzidine.  The second method used to identify the CjH3 antigen 
in isolated adherons entailed the isolation of adherons  from cultures of disso- 
ciated retina or brain cells that had been labeled overnight in methionine-free 
DME containing  10% dialyzed fetal calf serum with  10 um L-methionine and 
20 uCi/ml of [aSS]methionine (translation grade) (New England Nuclear, Bos- 
ton, MA). Adheron complexes were solubilized in immunoprecipitation  buffer 
(150 mM NaCI, 20 mM Na2HPO4, 1% Triton X- 100, 1% sodium deoxycholate, 
0.1% SDS, 1 mM benzamidine-HCl, 0.3 mM phenylmethylsulfonyl fluoride, 1 
mM  L-methionine  [pH  7.5]) as described  previously  (12) and analyzed  by 
PAGE.  For immunoprecipitation  of the CIH3 antigen,  solubilized adherons 
were incubated overnight at 4"C with Staphylococcus  aureus cells (Calbiochem- 
Behring Corp., San Diego, CA) that had been coated with goat anti-rat  whole 
serum and an excess of C~H3 monoclonal  antibody. Precipitated C~H3 antigen 
was solubilized in electrophoresis sample buffer, heated to  100*C for 5 min, 
and separated on 5% SDS polyacrylamide gels. 
Assay of Cell-Substratum Adhesion:  Cell-substratum  adhesion 
was assayed, with slight modifications,  according to published  methods (11). 
Day  11  retina  ceils or day  13  brain  ceils were mechanically dissociated and 
labeled 2-4 h with  10 uCi of [35S]methionine as outlined  previously. Labeled 
cells were washed  twice with  EBSS containing  0.2% albumin,  and  0.2-ml 
aliquots were pipetted into 35-mm plastic petri dishes, that contained  2 ml of 
the same medium and that had been coated with 30-50/ag of adheron protein. 
Dishes were incubated  1 h at 37"C and swirled l0 times to dislodge cells that 
adhere  weakly to the dish.  Medium  was then aspirated,  attached  ceils were 
dissolved in  Triton  X-100,  and  isotope  content was measured.  Under the 
conditions  employed  in  our studies,  the  assay of cell-substratum  adhesion 
represents the measurement of adhesive rate  because the binding  of cells to 
substratum is still rising after the 60-rain incubation. 
To examine the effect of C~H3 monoclonal  antibody (or other monoclonal 
antibodies) on cell-substratum  adhesion,  we incubated  0.2-ml  aliquots of la- 
beled cells for 30 min at 4"C, with  150 ~g of protein  of an immunoglobulin 
fraction  isolated  as described  previously  (13). Cells were then  washed with 
EBSS containing  0.2% albumin,  and their ability to attach  to adheron-coated 
dishes was assessed. 
To find  out if immunopurified  170,000-mol-wt C~Ha polypeptide  could 
promote adhesion, we coated glass vials with the antigen; subsequently, these 
vials were used  to measure  the rate  of cell-substratum  adhesion.  To attach 
immunopurified  antigen to the surface of glass vials, we used the protocol of 
Gottlieb  and Glaser (17). Briefly, we washed standard  glass scintillation vials 
with  nitric  acid and  then  treated  with  a  10%  solution  of 3,-aminopropyl- 
triethoxysilane in toluene for 2 h at room temperature.  The vials were washed 
with fresh toluene and air dried. A 1% aqueous solution of glutaraldehyde was 
then added  to the vial and left for l  h at room temperature.  After thorough 
washing with distilled water and air drying, the vials were incubated overnight 
with total adheron protein, immunopurified  antigen, or bovine serum albumin. 
Immunoaffinity  Purification of C1H3 Antigen:  Brains  were 
removed from 80 day-14 chick embryos and homogenized in 20 ml of  calcium- 
magnesium-free  medium containing  0.3  mM phenylmethylsulfonyl  fluoride 
and  1 mM EDTA. The homogenate  was centrifuged for 15  min at  12,000g 
and the pellets were resuspended in 2.25 M sucrose in 8 g of NaCI, 0.2 g of 
KC1, 0.2 g of KH2PO4, 0.15 g of Na2HPO4/liter (pH 7.4) (buffer A), according 
to published methods (18). The resuspended pellets were transferred to ultra- 
centrifuge  tubes and  then  overlaid  with  0.8  M  sucrose  in buffer  A.  After 
centrifugation  for 1 h at  100,000 g, the material at the interface between the 
two sucrose solutions was collected, washed twice with buffer A, and used for 
immunopurification  of C~H3 antigen. 
Before immunopurification,  day  14 brain  membranes were solubilized by 
overnight stirring in buffer A containing  1 mM EDTA, 0.5% Nonidet  P-40 
(NP-40), (pH 8.2). CjH3 monoclonal  antibody (5 mg/ml) was then coupled to 
CNBr-activated Sepharose 4B. The immunoaffinity  matrix was then incubated 
by end-over-end shaking for 1.5 h with the NP-40 extract of brain membranes. 
The immunoadsorbent  was washed twice with solubilization buffer as described 
by Hoffman et al. (18), and the immunoadsorbent was collected in a column 
and washed with three column volumes of buffer A containing  1 mM EDTA, 
0.5% NP-40. C~H3 antigen was eluted with 2.5 column volumes of buffer A 
containing  1 mM EDTA, 0.5% NP-40, 0.05 M diethylamine  (pH  11.5). The 
eluate was neutralized with 0.1 vol of 1.0 M potassium phosphate (pH 7.0) and 
detergent was removed by chromatography  on a column of Extracti-gel D (5 
ml of eluate/ml gel) (Pierce Chemical Co., Rockford, IL). The eluate was then 
dialyzed overnight against 500 volumes of H20 at 4°C, concentrated  by cen- 
trifugation  in  an Amicon  microconcentrator  (Amicon  Corp.  Scientific Sys. 
Div., Danvers, MA), and stored frozen at -70"C. 
Enzymatic Treatment of Adheron  Complexes:  The  role  of glycosaminoglycans  in cell-substratum adhesion was determined by incubating 
culture dishes coated with retina adheron protein with 1.0 U of chondroitinase 
ABC (Sigma Chemical Co., St.  Louis, MO), hyaluronidase (Sigma Chemical 
Co.) or heparitinase (Miles Laboratories, Elkhart, IN) in EBSS at 37"C for 30-- 
60 rain. Glycosaminoglycan breakdown was monitored by identically treating 
culture dishes in duplicate that had been coated with adheron protein obtained 
from retina cultures labeled  with  [35S]sulfate (Amersham Corp.,  Arlington 
Heights, IL). After enzymatic treatment, the culture dishes were washed three 
times with EBSS that contained 0.2% albumin, and cell-substratum adhesion 
was measured. 
The role  of polypeptides in cell-substratum adhesion was determined by 
incubating adheron-coated dishes with 0.01% trypsin (Sigma Chemical Co.) or 
0.01%  Subtilisin BPN protease (Sigma Chemical Co.) in EBSS at 37"C for 30 
min. Protein breakdown by enzyme treatment was estimated by identically 
treating culture dishes in duplicate that had been coated with [35S]methionine- 
labeled  adherons. Cell-substratum adhesion was subsequently assayed as out- 
lined above. 
RESULTS 
Brain Adherons Mediate Cell to Substratum 
Adhesion and Contain the 170,000-mol- 
wt Protein 
To examine the role of the 170,000-mol-wt CIH3 polypep- 
tide in  cell-substratum adhesion,  it is first necessary to im- 
munopurify the antigen using a monoclonal antibody affinity 
column. Since the C~ H3 monoclonal antibody recognizes two 
distinct polypeptides with molecular weights of 170,000  and 
140,000  in  embryonic chick  neural  retina,  but  only reacts 
with the 170,000-mol-wt component in embryonic brain (12), 
a  more feasible approach is to  use  embryonic chick brain 
tissue  for  the  immunopurification  of the  170,000-mol-wt 
protein. It was not known whether the brain 170,000-mol-wt 
protein was functionally identical to the retinal protein. To 
test this, we prepared brain adherons and used them to coat 
plastic dishes. The protocol for such experiments is shown in 
Fig.  1. The data in Fig. 2 show that brain adherons promote, 
in a  dose-dependent manner, the adhesion of brain cells to 
the dish,  and that this adhesion can be blocked with  CIH3 
antibody,  but  not  with  anti-N-CAM  antibody  (19).  Fig.  3 
illustrates that brain adherons and retinal adherons are func- 
tionally indistinguishable, in that both types of adherons are 
equally efficient in supporting the attachment of retinal cells 
or brain cells  3 to the substratum. 
The polypeptide composition of brain and retinal adherons 
biosynthetically labeled with [35S]methionine  is shown in Fig. 
4, lanes a and b. Although there are several differences in the 
composition  of  both  types  of  adherons,  both  contain  a 
170,000-mol-wt polypeptide. The CIH3 antibody can be uti- 
lized to specifically immunoprecipitate this polypeptide from 
dissociated brain  adherons (Fig.  4,  lane c).  N-CAM, which 
mediates cell to cell adhesion in many regions of the nervous 
system, is absent in adherons but present in the cells of origin. 
This is illustrated for retinal cells and retinal adherons in Fig. 
5 and Fig. 4, lane d. Although these data suggest that N-CAM 
and the  170,000-mol-wt C~H3 protein are distinct and unre- 
lated polypeptides, this cannot be stated with certainty. Recent 
evidence has indicated that some monoclonal antibodies to 
distinct cell adhesion molecules do exhibit cross-reactivity (5). 
3  We examined the binding of brain cells obtained from embryos of 
different ages to adheron-coated dishes obtained from I l-d-old em- 
bryonal brain cells that were maintained for 1 d in culture. Maximal 
adhesion is obtained with cells from  13-d-old embryos; these were 
used in all experiments. Cells from 11- or 15-d-old embryos adhere 
at about lh the rate of day 13 brain cells in this assay. 
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FIGURE  1  Schematic diagram of protocol for the isolation of ad- 
heron particles and the analysis of cell-substratum  adhesion.  Dis- 
sociated retinal or brain cells were incubated overnight at 37°C as 
described under Materials and Methods. The conditioned medium 
is then centrifuged at 100,000 g to sediment adheron particles. To 
assess cell-substratum  adhesion, we coated plastic culture dishes 
with  the  resuspended  adheron pellet and  then  incubated with 
[3SS]methionine-labeled  retinal or  brain  cells.  Cell to  substratum 
adhesion was quantitated by dissolving bound cells in Triton X-100 
and measuring  isotope content. As illustrated  in the graph,  cells 
bind  poorly to  uncoated plastic  but  bind  at  increased  rates to 
adheron-coated plastic. The role of specific macromolecules in cell 
to substratum adhesion can be examined  by employing monoclonal 
antibodies to block adhesion. 
It thus remains to be determined to what extent, if any, the 
170,000-mol-wt  CIHa  polypeptide  is  related  to  other  cell 
adhesion molecules in nervous tissue. 
We concluded that retinal and brain adherons are function- 
ally  indistinguishable,  and  that  the  brain-derived  170,000- 
mol-wt protein can be used to test whether cell  to adheron 
binding is due to this polypeptide. 
Effect of Immunopurified 170,O00-mol-wt C1H3 
Polypeptide on Cell-Substratum Adhesion 
Our observations,  taken  together with  previous observa- 
tions, indicated that embryonic chick brain and retinal cells 
employ a  similar mechanism  for cell-substratum adhesion, 
and that the mechanism of binding may be homophilic (i.e., 
binding required the interaction of like molecules on the cell 
surface and in the adheron complex), with the  170,000-mol- 
wt CzH3 polypeptide functioning as the adhesion molecule. 
We therefore investigated whether purified brain Cz H3 antigen 
could  disrupt  cell-substratum  adhesion.  To  isolate  the 
170,000-mol-wt antigen, embryonic day 14 brain membranes 
were solubilized in NP-40 and incubated with C~H3 mono- 
clonal  antibody  covalently  coupled  to  Sepharose-4B  08). 
Bound antigens were eluted with diethylamine (pH 11.5) and 
NP-40  was  removed  by  chromatography  on  a  detergent- 
affinity  column  and  extensive  dialysis.  The  purity  of the 
immunopurified antigen was assessed by PAGE. The 170,000- 
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FIGURE 2  Stimulation of cell-substratum  adhesion by brain adher- 
ons. Particulate material from conditioned medium of cultured brain 
cells was prepared as described. (A) 35 mm plastic Petri dishes were 
coated with  either 30  v,g (0)  or  50  /~g (ll)  of adheron protein. 
Dissociated day 12 brain cells that had been metabolically labeled 
with [~SS]methionine were added to the dishes and  incubated at 
37°C for the times  indicated. Following incubation, dishes were 
swirled gently to dislodge cells that were weakly adherent, medium 
was aspirated, and bound cells were dissolved  in Triton X-IO0 to 
measure isotope content.  Binding of cells  to  uncoated plastic  is 
indicated by open circles.  (B) Effect of monoclonal antibodies on 
cell-substratum  adhesion. Culture dishes were coated with 40/,g 
of adheron protein as described. Metabolically  labeled day 12 brain 
cells were then added to the dishes following either no treatment 
(0),  incubation with anti-N-CAM monoclonal antibody (x), or in- 
cubation  with  C~H3 monoclonal  antibody  (O). Cell-substratum 
adhesion was quantitated as described above. Anti-N-CAM mono- 
clonal antibody (19) was obtained from Dr. D. I. Gottlieb, Washing- 
ton University. 
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FIGURE 3  Adhesion of retinal and brain cells to their homologous 
or heterologous adherons.  Dissociated  day 11  retinal cells or day 
12  brain  cells  were  incubated for  18  h  in  serum-free  DME  as 
described under Materials and Methods. 35-mm plastic petri dishes 
were then coated with 30/zg of either day 12 retinal or day 13 brain 
adheron protein. Adhesion of metabolically labeled day 12 retinal 
or day 13 brain cells to these adheron-coated  dishes was measured 
at the times indicated. (A) Adhesion of labeled neural cells to retina 
adherons.  (B) Adhesion of labeled neural cells to brain adherons. 
(0) Day 12 retinal cells; (x) day 13 brain cells; (O) binding of neural 
cells to uncoated plastic. 
mol-wt  CIH3  polypeptide  is  the  predominant  polypeptide 
detected by staining with Coomassie Blue (Fig. 6), although a 
faint band  at  the  molecular weight  of 43,000  (presumably 
actin) was also detected. The band migrating at 170,000-mol- 
wt was confirmed as the C~H3 polypeptide by immunoblot- 
ring.  When partially purified antigen is transferred to nitro- 
cellulose and incubated with the QH3 antibody, a pronounced 
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FIGURE 4  SDS  PAGE of metabolically labeled adheron proteins. 
Cultures  of embryonic day 11  retinal cells, or day 12  brain  cells, 
were incubated overnight in Spinner  culture at 37 °C in the presence 
of  [~SS]methionine as  described  under  Materials  and  Methods. 
Aliquots containing similar  amounts of  radioactivity from  retinal 
adheron or  brain  adheron  pellets  were  then  separated  on  5% 
polyacrylamide gels. For immunoprecipitation (lanes c and CO, ad- 
heron pellets were solubilized in detergent  and incubated overnight 
at 4°C with S.  aureus  cells coated with goat anti-rat whole serum 
and C;H3 monoclonal antibody (lane c) or goat anti-mouse whole 
serum and anti-N-CAM monoclonal antibody (lane cO. Immunopre- 
cipitated polypeptides were separated on 5% polyacrylamide gels. 
(Lane a) Total polypeptides  contained in brain adheron preparation. 
The 170,000-mol-wt polypeptide is denoted by the arrow. (Lane b) 
Total polypeptides from retina adheron preparations.  (Lane c) Im- 
munoprecipitation of the 170,O00-mol-wt  polypeptide from brain 
adherons using the C;H3 monoclonal antibody. (Lane d) Immuno- 
precipitation of retina adherons using anti-N-CAM monoclonal an- 
tibody. Note the absence of N-CAM, as measured by immunopre- 
cipitation, in the adheron preparation. 
band at the molecular weight of 170,000  was detected (data 
not shown). However, a minor immunoreactive component 
that is stained after incubation with only secondary antibody 
(and thus is probably representative of the IgG heavy chain) 
was also observed (data not shown). 
Incubation  of dissociated  retinal  cells  with  the  purified 
170,000-mol-wt protein resulted in a  disruption of cell-sub- 
stratum  adhesion,  which  is  dependent  on  the  amount  of 
purified polypeptide added (Fig.  7). When  10 ug of the par- 
tially  purified  170,000-mol-wt  protein  were  added  to  the 
assay, the  inhibition  of adhesion  approached that observed 
with the CIH3 monoclonal antibody. In contrast, incubation 
of retinal  cells  with  similar amounts of total brain  protein 
that has been processed as described for the CIH3 antigen had 
little effect on  cell-substratum adhesion.  These results sup- 
ported  the  proposal  that  adheron-mediated  adhesion  may 
occur by a  homophilic mechanism  involving the  170,000- 
mol-wt CIH3 polypeptide. FIGURE  5  Dot-blotting of total retinal protein and retinal adheron 
protein using the C1H3 and anti-N-CAM monoclonal antibodies. 10 
#g of total  retinal  protein  (b  and  d)  or  25  #g of  retinal adheron 
protein (a and c) were blotted  onto nitrocellulose. The filter was 
then  incubated with C)H3  monoclonal antibody and  HRP-conju- 
gated  goat  anti-rat  IgG  or anti-N-CAM monoclonal antibody and 
HRP-conjugated  goat anti-mouse  IgG.  Binding was  visualized by 
reaction with 3,3'-diaminobenzidine and 0.01% hydrogen perox- 
ide. The C1H3 monoclonal antibody binds to protein in the adheron 
preparation,  while  anti-N-CAM  monoclonal  antibody  shows  no 
reactivity with the adheron. 
As described previously, it has been demonstrated that the 
CtH3 monoclonal antibody also recognizes a  140,000-mol-wt 
polypeptide that is distinct from the 170,000-mol-wt protein 
and that is only detected in early retinal tissue (12).  Because 
it appears that the antigenic determinant participates in cell- 
adheron binding, and that this determinant is shared by the 
170,000-mol-wt protein, we examined whether immunopu- 
rifled  140,000-mol-wt CIH3  polypeptide could impair cell- 
substratum  adhesion.  To immunopurify only the  140,000- 
mol-wt antigen, we solubilized 1,000 embryonic day-7 retinas 
(the  170,000-mol-wt molecule is  not  present  at  detectable 
levels in the retina at this age [12]) in NP-40, and chromato- 
graphed twice on a C~H3 monoclonal antibody affinity col- 
umn. PAGE of an aliquot of the 400 #g of protein that was 
eluted from the column with diethylamine indicated that the 
antigen was free of 170,000-mol-wt antigen (data not shown). 
Incubation of day 12 retinal cells with 10 #g of this material 
resulted in a pronounced inhibition of cell-substratum adhe- 
sion (Fig.  7).  Collectively, these data have shown that both 
CtH3 antigens contain an antigenic determinant that is capa- 
ble of binding to retinal cells  and blocking cell to adheron 
binding. 
Can Surfaces Coated with Immunopurified 
170,O00-mol-wt C1H3 Polypeptide Promote 
Cell-Substratum Adhesion? 
To  demonstrate  directly  that  the  170,000-mol-wt  CIH3 
protein mediates cell to adheron binding, we derivatized glass 
scintillation  vials  with  3,-aminopropyl-triethoxysilane, and 
subsequently coated them with purified 170,000-mol-wt pro- 
tein.  Vials  coated  with  partially  purified  protein  or  total 
adheron protein were capable of promoting cell-substratum 
adhesion (Fig.  8). The specificity of the response is demon- 
strated by the failure of the  100,000 g supernatant of condi- 
tioned medium to stimulate cell attachment. This result in- 
FIGURE  6  SDS  PAGE of  immunopurified  170,000-mol-wt  C1H3 
polypeptide. Membranes from 80 embryonic day-14 chick brains 
were solubilized in  buffer A containing 1 mM EDTA, 0.5% NP-40 
(pH 8.2) and incubated by end-over-end shaking with 3 ml of C~H3 
monoclonal antibody-Sepharose 4B. The Sepharose was collected 
in a  column  and  eluted  with three  column  vol  of  solubilization 
buffer. Bound protein was eluted with 2.5 column vol of buffer A 
containing 1 mM  EDTA,  0.5%  NP-40,  50  mM  diethylamine (pH 
11.5). Detergent was removed as described in Materials and Meth- 
ods, and aliquots of immunopurified protein were then heated  to 
100°C for 5 min in electrophoresis sample buffer and separated on 
a  7.5%  polyacrylamide gel.  Coomassie  Blue  staining of  15  #g  of 
immunopurified protein, separated by electrophoresis as described, 
is shown. The band at  43,000-mol-wt  probably represents  actin, 
since it is not detected by immunoblotting with the C~H3 antibody 
(data not shown). 
dicated that the  170,000-mol-wt CIH  3 protein by itself can 
promote retinal cell-substratum adhesion.  To rule out any 
possibility that the partially purified antigen promotes aohe- 
sion as a result of the presence of CIH3 monoclonal antibody 
in the preparation (with the antibody arising due to its release 
from the immunoaffinity column during elution), we assessed 
the ability of vials coated with small quantities of Cl H3 ascites 
fluid to promote adhesion. Amounts of CIH3 ascites protein 
equivalent to the total of 170,000-mol-wt protein used to coat 
the dish did not support the attachment of retinal cells to the 
substratum (Fig.  8). Note, however, that significantly higher 
levels  of the  170,000-mol-wt polypeptide were required to 
coat the dish to promote adhesion than were required when 
the  protein was  present  in  the  form of adherons.  Possible 
explanations for this apparent discrepancy will be presented 
in the Discussion. 
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FIGUre  7  Inhibition of attachment of labeled day 12 retinal cells 
to adheron-coated dishes by soluble immunopurified ClH3 antigen. 
Cell-substratum adhesion of metabolically labeled day  12  retinal 
cells  was measured, as previously described, in  the presence of 
immunopurified C1H3 antigen. Retinal cells were incubated 30 min 
at room temperature with 1-10 pg of 170,000-mol-wt protein, or 
10 pg of  140,000-mol-wt protein, washed three times with EBSS 
that contained 0.2% BSA, and added to adheron-coated dishes. As 
controls, retinal cells were either incubated with DME-15% horse 
serum or 10 pg of total brain protein that had been processed  as 
described  for  the  purification of  the  C,H3  antigen.  Number of 
experiments conducted (duplicate assays per experiment) are in- 
dicated in parentheses. 
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FIGURE  8  Attachment of  dissociated retinal cells  to  derivatized 
glass vials. Standard glass scintillation vials were derivatized with 3,- 
aminopropyl-triethoxysilane as  described  under  Materials  and 
Methods.  The  vials  were then  coated with  (a)  albumin,  (b)  the 
100,000 g culture supernatant protein, (c) 10 or 25 pg of adheron 
protein, (d) 10 pg of immunopurified 170,000-mol-wt C~H3 protein, 
or (e) 10 ~.g of C,H3 ascites protein. Additional binding sites on the 
derivatized glass surface  were blocked with EBSS that contained 
0.2% albumin, and metabolically labeled day 12 retinal cells were 
added to the vials. After a 60-min incubation, the vials were swirled 
gently, the medium was aspirated, and bound cells were dissolved 
in Triton X-100  (13). The  number of experiments conducted are 
indicated in parentheses. 
Effect of Enzymatic Treatment on 
Cell-Substratum  Adhesion 
To examine the role specific classes of macromolecules may 
play  in  adheron-mediated  cell  to  substratum  adhesion,  we 
treated retinal cell adheron complexes with a variety of pro- 
teases and glycosaminoglycan hydrolases. After enzyme treat- 
ment,  cell-substratum  adhesion  was measured.  Preliminary 
experiments  demonstrated  that  retina  and  brain  adherons 
respond in an identical manner to the various enzyme treat- 
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FIGURE  9  Effect of enzymatic treatments on cell-substratum adhe- 
sion.  Embryonic day  12  retinal adherons were prepared as  de- 
scribed, and used to coat 35 mm plastic Petri dishes with 30 pg of 
adheron protein. The adheron-coated dishes were then incubated 
at 370C for I  h with EBSS (control), 1.0 U of heparitinase, chon- 
droitinase ABC,  or hyaluronidase, or an 0.01% solution of either 
Subtilisin BPN  protease or trypsin. The treated dishes  were then 
washed extensively with EBSS that contained 0.2% BSA, and the 
rate of cell to substratum adhesion was determined after incubating 
the treated dishes with labeled retinal cells for I  h.  Note that the 
absence of any effect on adhesion by the glycosaminoglycan hy- 
drolases was not due to their failure to degrade glycosaminoglycan. 
When  35SO4-1abeled adheron-coated dishes  were  treated  with 
these enzymes, 30% of radioactivity was released from the dish by 
chondroitinase ABC, 25% by hyaluronidase, 20% by heparitinase, 
and 75% by Subtilisin BPN  protease. These values agree with the 
relative proportions of these glycosaminoglycans in retinal adher- 
ons, as reported by Schubert et al. (I I ). The number of experiments 
conducted are indicated in parentheses. 
ments. Therefore, only retinal adherons were used to examine 
the effect of enzymatic manipulation on cell-substratum adhe- 
sion.  When  adheron-coated  culture  dishes  were  incubated 
with either chondroitinase ABC, hyaluronidase, or hepariti- 
nase (which degrades heparan sulfate), and then used to test 
cell-substratum adhesion,  no significant effect was observed 
(Fig. 9). Because these enzymes failed to inhibit adhesion even 
when incubated overnight with adheron-coated dishes (data 
not shown), we suggest that the cell-binding receptor in ad- 
herons is not a glycosaminoglycan chain. The absence of any 
pronounced  effect  of these  enzymes on  adhesion  was  not 
likely due to their failure to break down glycosaminoglycans, 
since treatment of 35SO4-1abeled adherons released ~20-30% 
of the bound radioactivity for each enzyme tested (data not 
shown). These values are in close agreement with the relative 
proportion  of the  individual  glycosaminoglycan species  in 
retina adherons (11). 
In  contrast  to  the  data  described  above,  incubation  of 
adheron-coated dishes with several proteolytic enzymes pro- 
duced a significant reduction in the ability of the adherons to 
bind  retinal  cells  (Fig.  9A).  It  thus  appears  that  the  cell- 
binding molecule in adheron particles has the characteristics 
of a protein. 
DISCUSSION 
Previous studies in our laboratory have implicated a  170,000- 
mol-wt neural-specific polypeptide in  cell-substratum  adhe- sion (13).  This molecule is a component of adherons, which 
are complexes of proteins and glycosaminoglycan that pro- 
mote cell to substratum adhesion of neural retinal cells (11). 
Although adherons provide an in vitro assay system for the 
analysis of neural  cell-substratum adhesion,  we  think  they 
possess a  role  in  vivo  as  well.  The  170,000-mol-wt  C~H3 
protein is developmentally regulated (12), with its expression 
in vivo corresponding to the activity ofadherons in vitro. The 
170,000-mol-wt protein is also neural-specific, and adheron- 
mediated adhesion is known to be tissue-specific, as demon- 
strated by the inability of muscle cells to attach significantly 
to retina adherons (11).  The data presented has shown that 
brain  adherons and  retinal  adherons,  although  differing in 
molecular composition, are essentially indistinguishable func- 
tionally, and both can bind retinal cells as well as brain cells. 
We found that if the antibody was incubated with the cells 
or the adherons before assay, the binding of retinal cells to 
adherons was blocked by the CIH3 antibody.  This suggests 
that the binding was homophilic in that molecules that con- 
tained the C~H3 determinant in retinal  cells  (or brain cells) 
and in the adherons interacted with each other. This homo- 
philic interaction between 170,000-mol-wt protein molecules 
probably represents only one part of an adhesion process that 
may be very complex and  involve additional  molecules on 
the cell surface. The 170,000-mol-wt protein present in both 
cells and adherons is not solely responsible for cell to adheron 
binding; this is emphasized by the developmental regulation 
of cell to adheron binding, which is maximal at day 11-12 in 
the retina (11) and at day  13  in the brain, even though the 
concentration  of  170,000-mol-wt  protein  continues  to  in- 
crease beyond that age. 
The soluble 170,000-mol-wt protein has been shown to also 
block cell-adheron binding, which implies that it can interact 
with the cellular site(s) that bind to adherons, and that other 
components  in  the  adheron,  namely  glycosaminoglycans, 
may not be required for binding. For example, treatment of 
adherons with glycosaminoglycan hydrolases does not prevent 
binding. However, as discussed previously, the developmental 
regulation of adheron activity suggests that components other 
than the 170,000-mol-wt C~H3 polypeptide participate in cell- 
adheron binding. 
When  used to coat glass vials,  10  ug of immunopurified 
170,000-mol-wt protein  promoted cell  to substratum adhe- 
sion at a rate comparable to that obtained by coating the glass 
with 25 ~g of adherons. We estimate that 25 #g of adherons 
contains  0.5  ug  of the  170,000-mol-wt  protein.  Thus,  the 
immunopurified protein is 20 times less effective than adher- 
ons in this assay, assuming that both coat the  surface with 
equal efficiency. This discrepancy can be explained in several 
ways: (a) It is possible that the  immunopurified protein  is 
partially denatured, though immunopurification by different 
means has not changed the activity of the soluble protein in 
this assay. (b) The soluble, immunopurified  170,000-mol-wt 
protein may possess a lower affinity for retinal cells than the 
intact  adherons.  (c)  When  the  170,000-mol-wt  protein  is 
bound to the dish in the form of adherons, its local concen- 
tration is as high as it is in the adheron. The soluble protein, 
however,  is  uniformly distributed  on  the glass  surface and 
much  higher  concentrations  may therefore be  required  to 
attain the same density. Cell to cell (20) and cell to substratum 
adhesion  (when  assayed  with  simple  carbohydrate  ligands 
[21])  are  known  to  require  a  local  clustering  of  ligands. 
Although  our assay  systems are  somewhat different,  these 
results in related systems predict that higher concentrations 
of the soluble 170,000-moi-wt protein (compared with adher- 
ons) would be required to coat the glass surface in order to 
mediate cell  adhesion effectively. This might require that a 
cell bind to the substratum at multiple sites in order to remain 
attached during the washing procedure. Recent experiments 
with synthetic peptides of the cell-binding domain of fibro- 
nectin have also shown that high concentrations (millimolar 
range) of the peptide are required to obtain 50% inhibition of 
cell-substratum adhesion (22).  This study therefore supports 
our observations that large quantities of soluble antigen are 
needed to significantly inhibit cell to substratum adhesion. 
The proposal that the 170,000-mol-wt protein in adherons 
binds with a  higher affinity to the cellular molecule merits 
further  analysis,  particularly  since  a  homophilic  binding 
mechanism was suggested by our data.  Homophilic binding 
between  N-CAM  molecules  in  neurons  has  been  demon- 
strated to mediate in part neuron-neuron interactions in the 
nervous system (23,  24).  In light of these data, cell-adheron 
binding would be inefficient if cellular  170,000-mol-wt pro- 
teins interacted with neighboring cellular antigens as well as 
they bound adheron antigens. As discussed above, the devel- 
opmental regulation  of adheron  activity implies that  addi- 
tional molecules in the adheron complex are involved in cell- 
adheron  interactions.  Although  the  precise  role  of such  a 
molecule(s)  is  unknown,  they  may  promote  adhesion  by 
conferring  a  greater  cell-binding  activity  to  the  adheron 
170,000-mol-wt protein. 
Experiments are currently in progress in our laboratory to 
further explore the possible role of additional macromolecules 
in  adheron-mediated  cell-substratum  adhesion.  The  use  of 
liposome vesicles that contain  170,000-mol-wt polypeptides 
should  also  show  whether  the  vesicles bind  with  a  higher 
affinity to adherons than to other vesicles.  It will ultimately 
be of interest to determine if an active cell-adheron binding 
domain can be isolated, thereby permitting a  more detailed 
characterization of the mechanism of cell-substratum attach- 
ment. Experiments are currently in progress to enzymatically 
digest the immunopurified 170,000-mol-wt protein, with the 
aim of identifying and isolating an immunoreactive fragment 
that can block cell to adheron binding. 
Although the 170,000-mol-wt fill3 polypeptide appears to 
be  chemically  and  functionally  distinct  from  N-CAM,  its 
molecular weight is similar to polypeptides with an adhesive 
function from a host of other tissues.  In embryonic nervous 
tissue, cell adhesion molecules similar in size to the 170,000- 
mol-wt CIH3 protein have been described in the neural retina 
(1,  18,  25)  and  in  the  cerebellum (3,  4).  Cognin,  a  neural 
retina  cell  aggregation-promoting  factor  with  a  molecular 
weight  of 50,000,  has  also  been  characterized  (26),  and  is 
similar to  the  CIH3 polypeptide in  that  it  was  isolated by 
sedimentation  from conditioned  culture  medium  (27)  and 
was purified from neural retina cell  membranes (28).  Since 
cognin shares characteristics with the  170,000-mol-wt C~H3 
protein, it remains to be determined whether it is present in 
adherons and participates in cell-adheron attachment. 
Macromolecules involved in  cell-substratum adhesion  of 
non-neural cell types have been identified and resemble the 
C~H3 antigen.  For example, polypeptides with  a  molecular 
weight of 120,000-160,000  that are required for cell-matrix 
interactions in muscle have been described (29,  30). In fibro- 
blast  and  epithelial  cells,  glycoproteins  with  a  molecular 
weight of 120,000-140,000  that are released into the culture 
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substratum (31-33). In addition, the attachment of  pheochro- 
mocytoma cells to culture dish plastic  is enhanced by adher- 
ons from smooth muscle cell lines  (34).  These data suggest 
that cell-substratum adhesion molecules from different cell 
types  share  a  number  of characteristics,  which  include  a 
similar molecular size and the  release  of the  adhesion-pro- 
moting factor into the culture medium. It is thus of interest 
to further examine the physiological  role of these molecules, 
particularly with respect to adhesive  processes,  both in vitro 
and in vivo. 
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